San Diego, CA -- (SBWIRE) -- 08/15/2019 -- An investigation on behalf of investors, who currently hold shares of Corindus Vascular Robotics, Inc. (NYSE: CVRS), was announced concerning whether the takeover of Corindus Vascular Robotics, Inc. is unfair to NYSE: CVRS stockholders.

Investors who purchased shares of Corindus Vascular Robotics, Inc. (NYSE: CVRS) and currently hold any of those NYSE: CVRS shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain officers and directors of Corindus Vascular Robotics, Inc. breached their fiduciary duties owed to NYSE: CVRS investors in connection with the proposed acquisition.

Waltham, MA based Corindus Vascular Robotics, Inc. designs, manufactures, and sells robotic-assisted systems for use in interventional vascular procedures in the United States and internationally. On August 8, 2019, Corindus Vascular Robotics, Inc. announced that it has entered into a merger agreement to be acquired by Siemens Healthineers AG. Under the terms of the merger agreement, Siemens Medical Solutions, a wholly-owned subsidiary of Siemens Healthineers AG, a German stock listed company, will acquire all issued and outstanding shares of common stock of Corindus for $4.28 per share in cash, representing an aggregate purchase price of approximately $1.1 billion.

However, the investigation concerns whether the offer is unfair to NYSE: CVRS stockholders. More specifically, the investigation concerns whether the Corindus Vascular Robotics Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.

On August 14, 2019, shares of Corindus Vascular Robotics, Inc. (NYSE: CVRS) closed at $4.26 per share.

Those who are current investors in Corindus Vascular Robotics, Inc. (NYSE: CVRS) shares have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.